France considers breast screening for 40-49 age group
This article was originally published in Clinica
The French national healthcare accreditation and evaluation agency, Anaes, has advised its government that there is still not enough evidence to suggest that it is worth extending the French national breast cancer screening programme to women aged between 40 and 49. Screening is currently offered every other year to those aged between 50 and 74.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.